Skip to main content
SpringerLink
Log in

Vitamin D and Its Effects on the Heart

  • Chapter
  • First Online:
Cardio-Renal Clinical Challenges

  • 1370 Accesses

Abstract

A 67 year-old gentleman with hypertension, hyperlipidemia, heart failure with preserve ejection fraction (left ventricular ejection fraction 65 %), symmetric left ventricular hypertrophy, chronic kidney disease Stage 3B presents in follow up of his multiple cardiovascular issues. He has a normal serum calcium level and his parathyroid hormone is within target range. Would this patient benefit of vitamin D treatment and if so, which form and dose of vitamin D?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Holick MF. Vitamin D, deficiency. N Engl J Med. 2007;357(3):266–81.

    Article  CAS  PubMed  Google Scholar 

  2. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998;338(12):777–83.

    Article  CAS  PubMed  Google Scholar 

  3. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, de Simone G, et al. Executive summary: heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation. 2010;121(7):948–54.

    Article  PubMed  Google Scholar 

  4. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117(4):e25–146.

    Article  PubMed  Google Scholar 

  5. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353(9147):89–92.

    Article  CAS  PubMed  Google Scholar 

  6. Tishkoff DX, Nibbelink KA, Holmberg KH, Dandu L, Simpson RU. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology. 2008;149(2):558–64.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. O’Connell TD, Simpson RU. Immunochemical identification of the 1,25-dihydroxyvitamin D3 receptor protein in human heart. Cell Biol Int. 1996;20(9):621–4.

    Article  PubMed  Google Scholar 

  8. Bhan I, Tamez H, Thadhani RI. Impact of new vitamin D data on future studies and treatment. Curr Opin Nephrol Hypertens. 2013;22(4):377–82.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Tamez H, Thadhani RI. Vitamin D and hypertension: an update and review. Curr Opin Nephrol Hypertens. 2012;21(5):492–9.

    Article  CAS  PubMed  Google Scholar 

  10. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503–11.

    Article  CAS  PubMed  Google Scholar 

  11. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168(11):1174–80.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Sun Q, Shi L, Rimm EB, Giovannucci EL, Hu FB, Manson JE, et al. Vitamin D intake and risk of cardiovascular disease in US men and women. Am J Clin Nutr. 2011;94(2):534–42.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Brondum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG. 25-hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol. 2012;32(11):2794–802.

    Article  CAS  PubMed  Google Scholar 

  14. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168(12):1340–9.

    Article  CAS  PubMed  Google Scholar 

  15. Wolf M, Shah A, Gutiérrez OM, Ankers E, Monroy M, Tamez H, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007;72(8):1004–13.

    Article  CAS  PubMed  Google Scholar 

  16. van Ballegooijen AJ, Snijder MB, Visser M, van den Hurk K, Kamp O, Dekker JM, et al. Vitamin D in relation to myocardial structure and function after eight years of follow-up: the Hoorn study. Ann Nutr Metab. 2012;60(1):69–77.

    Article  PubMed  Google Scholar 

  17. Fall T, Shiue I, Bergeå af Geijerstam P, Sundström J, Arnlöv J, Larsson A, et al. Relations of circulating vitamin D concentrations with left ventricular geometry and function. Eur J Heart Fail. 2014;14(9):985–91.

    Article  Google Scholar 

  18. Liu LCY, Voors AA, van Veldhuisen DJ, van der Veer E, Belonje AM, Szymanski MK, et al. Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail. 2014;13(6):619–25.

    Article  Google Scholar 

  19. Pilz S, März W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab. 2008;93(10):3927–35.

    Article  CAS  PubMed  Google Scholar 

  20. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49(5):1063–9.

    Article  CAS  PubMed  Google Scholar 

  21. Margolis KL, Martin LW, Ray RM, Kerby TJ, Allison MA, Curb JD, et al. A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women. Am J Epidemiol. 2012;175(1):22–32.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013;369(21):1991–2000.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension. 1997;30(2 Pt 1):150–6.

    Article  CAS  PubMed  Google Scholar 

  24. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr. 2005;94(4):483–92.

    Article  CAS  PubMed  Google Scholar 

  25. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani RI, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007;167(11):1159–65.

    Article  CAS  PubMed  Google Scholar 

  26. Snijder MB, Lips P, Seidell JC, Visser M, Deeg DJH, Dekker JM, et al. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med. 2007;261(6):558–65.

    Article  CAS  PubMed  Google Scholar 

  27. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629–37.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol. 2008;102(11):1540–4.

    Article  CAS  PubMed  Google Scholar 

  29. Amirlak I, Al Dhaheri W, Narchi H. Dilated cardiomyopathy secondary to nutritional rickets. Ann Trop Paediatr. 2008;28(3):227–30.

    Article  CAS  PubMed  Google Scholar 

  30. Chehade H, Girardin E, Rosato L, Cachat F, Cotting J, Perez MH. Acute life-threatening presentation of vitamin D deficiency rickets. J Clin Endocrinol Metab. 2011;96(9):2681–3.

    Article  CAS  PubMed  Google Scholar 

  31. Gupta P, Radhakrishnan S, Tomar M, Shrivastava S. Hypocalcemic cardiomyopathy presenting as cardiogenic shock. Ann Pediatr Cardiol. 2011;4(2):152.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Kim BG, Chang SK, Kim SM, Hwang JS, Jung J-W. Dilated cardiomyopathy in a 2 month-old infant: a severe form of hypocalcemia with vitamin d deficient rickets. Korean Circ J. 2010;40(4):201–3.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Maiya S, Sullivan I, Allgrove J, Yates R, Malone M, Brain C, et al. Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure. Heart. 2008;94(5):581–4.

    Article  CAS  PubMed  Google Scholar 

  34. Tiosano D, Schwartz Y, Braver Y, Hadash A, Gepstein V, Weisman Y, et al. The renin-angiotensin system, blood pressure, and heart structure in patients with hereditary vitamin D-resistance rickets (HVDRR). J Bone Miner Res. 2011;26(9):2252–60.

    Article  CAS  PubMed  Google Scholar 

  35. Ameri P, Canepa M, Milaneschi Y, Spallarossa P, Leoncini G, Giallauria F, et al. Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging. J Intern Med. 2013;273(3):253–62.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. van Ballegooijen AJ, Visser M, Cotch MF, Arai AE, Garcia M, Harris TB, et al. Serum vitamin D and parathyroid hormone in relation to cardiac structure and function: the ICELAND-MI substudy of AGES-Reykjavik. J Clin Endocrinol Metab. 2013;98(6):2544–52.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Bucharles S, Barberato SH, Stinghen AE, Gruber B, Piekala L, Dambiski AC, et al. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism. J Ren Nutr. 2012;22(2):284–91.

    Article  CAS  PubMed  Google Scholar 

  38. Agarwal M, Phan A, Willix Jr R, Barber M, Schwarz ER. Is vitamin D deficiency associated with heart failure? A review of current evidence. J Cardiovasc Pharmacol Ther. 2011;16(3–4):354–63.

    Article  CAS  PubMed  Google Scholar 

  39. Jorde R, Figenschau Y, Emaus N, Hutchinson M, Grimnes G. Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension. 2010;55(3):792–8.

    Article  CAS  PubMed  Google Scholar 

  40. Leckstroem DC, Salzer J, Goldsmith DJ. The trials and tribulations of vitamin D: time for the ‘sunshine’ vitamin to come in out of the cold – or just more broken promises? Expert Rev Endocrinol Metabol. 2014;9:1–18.

    Article  Google Scholar 

  41. Uysal S, Kalayci AG, Baysal K. Cardiac functions in children with vitamin D deficiency rickets. Pediatr Cardiol. 1999;20(4):283–6.

    Article  CAS  PubMed  Google Scholar 

  42. Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis. 1999;33(1):73–81.

    Article  CAS  PubMed  Google Scholar 

  43. Lemmilä S, Saha H, Virtanen V, Ala-Houhala I, Pasternack A. Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis. Am J Nephrol. 1998;18(5):404–10.

    Article  PubMed  Google Scholar 

  44. Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, et al. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol. 2010;5(5):905–11.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  45. Thadhani RI, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H, et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA. 2012;307(7):674–84.

    Article  CAS  PubMed  Google Scholar 

  46. Wang AY-M, Fang F, Chan J, Wen Y-Y, Qing S, Chan IH-S, et al. Effect of paricalcitol on left ventricular mass and function in CKD–the OPERA trial. J Am Soc Nephrol. 2014;25(1):175–86.

    Article  CAS  PubMed  Google Scholar 

  47. Shedeed SA, Vitamin D. Supplementation in infants with chronic congestive heart failure. Pediatr Cardiol. 2012;33(5):713–9.

    Article  PubMed  Google Scholar 

  48. Larsen T, Mose FH, Bech JN, Hansen AB, Pedersen EB. Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens. 2012;25(11):1215–22.

    Article  CAS  PubMed  Google Scholar 

  49. Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115(7):846–54.

    Article  CAS  PubMed  Google Scholar 

  50. Trivedi DP, Doll R, Khaw K-T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003;326(7387):469.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  51. Prince RL, Austin N, Devine A, Dick IM, Bruce D, Zhu K. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med. 2008;168(1):103–8.

    Article  CAS  PubMed  Google Scholar 

  52. Bodyak N, Ayus JC, Achinger S, Shivalingappa V, Ke Q, Chen Y-S, et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci U S A. 2007;104(43):16810–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  53. Li YC, Kong J, Wei M, Chen Z-F, Liu SQ, Cao L-P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110(2):229–38.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  54. Wu J, Garami M, Cheng T, Gardner DG. 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest. 1996;97(7):1577–88.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  55. Tamez H, Zoccali C, Packham D, Wenger J, Bhan I, Appelbaum E, et al. Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease. Am Heart J. 2012;164(6):902–9.

    Article  CAS  PubMed  Google Scholar 

  56. Tamez H, Kalim S, Thadhani RI. Does vitamin D modulate blood pressure? Curr Opin Nephrol Hypertens. 2013;22(2):204–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  57. Manson JE, Bassuk SS, Lee I-M, Cook NR, Albert MA, Gordon D, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials. 2012;33(1):159–71.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  58. Chen S, Glenn DJ, Ni W, Grigsby CL, Olsen K, Nishimoto M, et al. Expression of the vitamin D receptor is increased in the hypertrophic heart. Hypertension. 2008;52(6):1106–12.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  59. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab. 2001;86(2):888–94.

    CAS  PubMed  Google Scholar 

  60. Weishaar RE, Simpson RU. Vitamin D3 and cardiovascular function in rats. J Clin Invest. 1987;79(6):1706–12.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Weishaar RE, Kim SN, Saunders DE, Simpson RU. Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties. Am J Physiol. 1990;258(1 Pt 1):E134–42.

    CAS  PubMed  Google Scholar 

  62. Thierry-Palmer M, Carlyle KS, Williams MD, Tewolde T, Caines-McKenzie S, Bayorh MA, et al. Plasma 25-hydroxyvitamin D concentrations are inversely associated with blood pressure of Dahl salt-sensitive rats. J Steroid Biochem Mol Biol. 1998;66(4):255–61.

    Article  CAS  PubMed  Google Scholar 

  63. Choi JH, Ke Q, Bae S, Lee JY, Kim YJ, Kim UK, et al. Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats. J Card Fail. 2011;17(12):1051–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  64. Bae S, Yalamarti B, Ke Q, Choudhury S, Yu H, Karumanchi SA, et al. Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats. Cardiovasc Res. 2011;91(4):632–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  65. Mizobuchi M, Nakamura H, Tokumoto M, Finch J, Morrissey J, Liapis H, et al. Myocardial effects of VDR activators in renal failure. J Steroid Biochem Mol Biol. 2010;121(1–2):188–92.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  66. Przybylski R, Mccune S, Hollis B, Simpson RU. Vitamin D deficiency in the spontaneously hypertensive heart failure [SHHF] prone rat. Nutr Metab Cardiovasc Dis. 2010;20(9):641–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  67. Kong J, Kim GH, Wei M, Sun T, Li G, Liu SQ, et al. Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats. Am J Pathol. 2010;177(2):622–31.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  68. Gupta GK, Agrawal T, DelCore MG, Mohiuddin SM, Agrawal DK. Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hypercholesterolemic swine. Exp Mol Pathol. 2012;93(1):82–90.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  69. Meems LMG, Cannon MV, Mahmud H, Voors AA, van Gilst WH, Silljé HHW, et al. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload. J Steroid Biochem Mol Biol. 2012;132(3–5):282–9.

    Article  CAS  PubMed  Google Scholar 

  70. Koleganova N, Piecha G, Ritz E, Gross ML. Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats. Nephrol Dial Transplant. 2008;24(3):778–87.

    Article  PubMed  Google Scholar 

  71. Xiang W, Kong J, Chen S, Cao L-P, Qiao G, Zheng W, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab. 2005;288(1):E125–32.

    Article  CAS  PubMed  Google Scholar 

  72. Chen S, Law CS, Grigsby CL, Olsen K, Hong T-T, Zhang Y, et al. Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation. 2011;124:1838–47.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  73. Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE, et al. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem. 2007;282(41):29821–30.

    Article  CAS  PubMed  Google Scholar 

  74. Chen S, Gardner DG. Liganded vitamin D receptor displays anti-hypertrophic activity in the murine heart. J Steroid Biochem Mol Biol. 2013;136:150–5.

    Article  CAS  PubMed  Google Scholar 

  75. Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int. 2008;74(2):170–9.

    Article  CAS  PubMed  Google Scholar 

  76. Zhang Y, Kong J, Deb DK, Chang A, Li YC. Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system. J Am Soc Nephrol. 2010;21(6):966–73.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  77. Weber KT, Weglicki WB, Simpson RU. Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium. Cardiovasc Res. 2008;81(3):500–8.

    Article  PubMed Central  PubMed  Google Scholar 

  78. Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest. 2007;117(3):568–75.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  79. Rahman A, Hershey S, Ahmed S, Nibbelink K, Simpson RU. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol. 2007;103(3–5):416–9.

    Article  CAS  PubMed  Google Scholar 

  80. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM. 2002;95(12):787–96.

    Article  CAS  PubMed  Google Scholar 

  81. Weng S, Sprague JE, Oh J, Riek AE, Chin K, Garcia M, et al. Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice. PLoS One. 2013;8(1):e54625.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  82. Takeda M, Yamashita T, Sasaki N, Nakajima K, Kita T, Shinohara M, et al. Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol. 2010;30(12):2495–503.

    Article  CAS  PubMed  Google Scholar 

  83. Oh J, Weng S, Felton SK, Bhandare S, Riek A, Butler B, et al. 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation. 2009;120(8):687–98.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  84. Riek AE, Oh J, Sprague JE, Timpson A, de las Fuentes L, Bernal-Mizrachi L, et al. Vitamin D suppression of endoplasmic reticulum stress promotes an antiatherogenic monocyte/macrophage phenotype in type 2 diabetic patients. J Biol Chem. 2012;287(46):38482–94.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Massachusetts General Hospital, 55 Fruit St. GRB 1008-G, Boston, MA, 02114, USA

    Hector Tamez MD, MPH

  2. Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA

    Guillermo Ortiz San-Juan MD & Ravi I. Thadhani (Professor of Medicine, Chief)

  3. Harvard Medical School, Boston, MA, USA

    Ravi I. Thadhani (Professor of Medicine, Chief)

Authors
  1. Hector Tamez MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guillermo Ortiz San-Juan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ravi I. Thadhani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hector Tamez MD, MPH .

Editor information

Editors and Affiliations

  1. Renal and Transplantation Department, Guy's Hospital, London, United Kingdom

    David Goldsmith

  2. Gr. T. Popa University of Medicine and Pharmacy, Iasi, Romania

    Adrian Covic

  3. Karolinska Institutet Danderyd University Hospital, Stockholm, Sweden

    Jonas Spaak

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Tamez, H., San-Juan, G.O., Thadhani, R.I. (2015). Vitamin D and Its Effects on the Heart. In: Goldsmith, D., Covic, A., Spaak, J. (eds) Cardio-Renal Clinical Challenges. Springer, Cham. https://doi.org/10.1007/978-3-319-09162-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-09162-4_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-09161-7

  • Online ISBN: 978-3-319-09162-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation